Propranolol: Indications and Dosing in Adults
Propranolol is FDA-approved for hypertension, angina pectoris, migraine prophylaxis, and hypertrophic subaortic stenosis in adults, with typical dosing ranging from 80-320 mg daily depending on the indication 1.
FDA-Approved Indications in Adults
The following are the established indications for propranolol in adults without contraindications 1:
1. Hypertension
- Can be used alone or combined with thiazide diuretics
- Not indicated for hypertensive emergencies
- Typical dosing: 80-320 mg daily 2
- Once-daily dosing is effective for patients already controlled on divided doses 2
2. Angina Pectoris Due to Coronary Atherosclerosis
- Decreases angina frequency and increases exercise tolerance
- Mean effective dose: 255 mg daily 3
- Patients achieving ≥50% reduction in anginal episodes have significantly lower mortality 3
- Post-myocardial infarction: 180-240 mg/day reduces total mortality and sudden cardiac death 4
3. Migraine Prophylaxis
- Optimal doses: 160-240 mg daily 5
- Not effective for acute migraine treatment 1
- Many patients receive suboptimal doses in practice 5
4. Hypertrophic Subaortic Stenosis
- Improves NYHA functional class in symptomatic patients 1
Dosing Principles
General Dosing Guidelines
- Therapeutic plasma levels: >20 ng/mL required for significant beta-blockade 6
- Minimum effective daily dose: Slightly above 160 mg to achieve therapeutic levels 6
- Approximately 50% of patients achieve adequate beta-blockade at 160 mg/day 6
Acute Cardiovascular Settings
For tachyarrhythmias in emergency settings 7:
- IV dosing: 0.5-1 mg over 1 minute
- Can repeat up to total dose of 0.1 mg/kg if required
- Used for stable narrow-complex tachycardias and ventricular rate control in atrial fibrillation/flutter
Absolute Contraindications
Propranolol must not be used in patients with 1:
- Cardiogenic shock
- Sinus bradycardia and greater than first-degree heart block
- Bronchial asthma
- Known hypersensitivity to propranolol
Important Clinical Considerations
Relative Contraindications
- Previous congestive heart failure history increases risk 3
- Cardiothoracic ratio >0.5 predicts heart failure development within 3 years 3
- Obstructive airway disease (though mild asthma may be dose-related and manageable) 3
Common Side Effects
More frequent than placebo 4:
- Hypotension
- Gastrointestinal symptoms
- Fatigue
- Bronchospasm
- Cold extremities
Critical Safety Points
- Cardiogenic shock risk: May increase mortality in acute MI patients who develop cardiogenic shock 3
- Heart failure: Develops in 25% of patients on long-term therapy, particularly those with prior CHF or large cardiac silhouette 3
- No tachyphylaxis: Long-term effectiveness maintained without tolerance development 3
Off-Label Uses (Emerging Evidence)
While not FDA-approved, propranolol shows promise for:
- Stage fright and performance anxiety 8
- Post-traumatic stress disorder 8
- Behavioral and psychological symptoms of dementia (agitation/aggression), though routine use cannot be recommended given limited data 9
Practical Prescribing Algorithm
- Verify no absolute contraindications (cardiogenic shock, heart block, bradycardia, asthma, hypersensitivity)
- Assess relative contraindications (CHF history, cardiothoracic ratio >0.5, obstructive airway disease)
- Start at appropriate dose for indication:
- Hypertension: 80-160 mg daily
- Angina: 180-255 mg daily
- Migraine prophylaxis: 160-240 mg daily
- Titrate based on response and tolerability up to maximum 320 mg daily
- Monitor for hypotension, bradycardia, and heart failure symptoms